Levetiracetam Stada

Levetiracetam is a medicine used to treat epileptic seizures.

Form
tabletti, kalvopäällysteinen
Strength
250 mg
Active Ingredient
Levetiracetam
Manufacturer
STADA Arzneimittel AG

How to Use

Dosage

The usual dose for adults and adolescents over 12 years (over 50 kg) is 1000–3000 mg daily. Your doctor will usually start with a lower dose.

Method

Take the tablets twice a day, in the morning and in the evening, at about the same time each day. Swallow the tablets with water. You can take them with or without food.

Important

A maximum of 3000 mg per day.

Possible Side Effects

COMMON
  • Stuffy or runny nose, sore throat
  • Feeling sleepy
  • Headache
  • Loss of appetite
  • Feeling down, angry, anxious, having trouble sleeping, or feeling nervous or irritable
  • Seizures, balance problems, dizziness, lack of energy, or shaking
  • Feeling like things are spinning
  • Cough
  • Stomach pain, diarrhea, upset stomach, vomiting, or feeling sick
  • Skin rash
  • Feeling weak or tired
RARE
  • Low numbers of blood cells (platelets, white blood cells)
  • Weight changes
  • Thoughts of suicide, mental problems, strange behavior, seeing or hearing things that aren't there (hallucinations), anger, confusion, panic attacks, mood changes, or feeling agitated
  • Memory loss, clumsiness, tingling skin, or trouble concentrating
  • Double or blurry vision
  • Abnormal liver test results
  • Hair loss, skin rash (eczema), or itching
  • Muscle weakness or muscle pain
  • Injury
  • Infection
  • Very low numbers of all types of blood cells
  • Serious allergic reactions (like severe rash with fever, swelling of the face/throat)
  • Low sodium in the blood
  • Suicide, behavioral problems, or trouble thinking clearly
  • Severe confusion (delirium)
  • Brain disease
  • Seizures getting worse or happening more often
  • Uncontrolled muscle movements or hyperactivity
  • Changes in heart rhythm
  • Inflammation of the pancreas
  • Liver failure or inflammation of the liver
  • Sudden kidney problems
  • Muscle breakdown (rhabdomyolysis) with high levels of a muscle enzyme in the blood
  • Trouble walking or limping

Important Warnings

  • Weakness, feeling dizzy or lightheaded, or difficulty breathing, as these can be signs of a severe allergic reaction. Seek immediate medical attention.
  • Swelling of the face, lips, tongue, and throat (angioedema). Seek immediate medical attention.
  • Flu-like symptoms and a rash on the face, followed by a widespread rash with high fever, changes in blood tests, or enlarged lymph nodes (DRESS syndrome). Seek immediate medical attention.
  • Low urine output, tiredness, nausea, vomiting, confusion, and swelling in the legs, ankles, or feet, as these can be signs of sudden kidney problems. Seek immediate medical attention.
  • A rash that can form blisters and look like small targets (erythema multiforme), widespread blistering rash and peeling skin (Stevens-Johnson syndrome), or a more severe form of rash causing skin peeling over more than 30% of the body (toxic epidermal necrolysis). Seek immediate medical attention.
Show 5 more warnings
  • Serious mental or behavioral changes like confusion, drowsiness, memory loss, abnormal behavior, or uncontrolled movements, which can be signs of a brain disease. Seek immediate medical attention.
  • If you have kidney problems, your doctor might need to adjust your dose.
  • Some people taking epilepsy medicines, including Levetiracetam Stada, have had thoughts of harming themselves or suicide. If you have symptoms of depression or suicidal thoughts, contact your doctor.
  • Your epilepsy may get worse, or you may have more seizures, especially during the first month of treatment or after increasing the dose. Contact your doctor immediately if this happens.
  • Do not use Levetiracetam Stada if you are allergic to levetiracetam or any other ingredients in this medicine.

Use in Elderly Patients

Category C

Suitable for older adults, with specific precautions. Sedative. Reduce the dose already in mild renal impairment. Consider possibility of mental disorders. (updated 6.10.2025)